Document is current
Any future updates will be listed below
-
Authors
Giraldez, Maria D. https://orcid.org/0000-0001-6829-7603
Carneros, David https://orcid.org/0000-0001-5124-4708
Garbers, Christoph https://orcid.org/0000-0003-4939-6950
Rose-John, Stefan https://orcid.org/0000-0002-7519-3279
Bustos, Matilde https://orcid.org/0000-0003-2306-9548
- License Information
-
More Information
Article History
Accepted: 20 May 2021
First Online: 1 July 2021
Competing interests
: S.R.-J. has acted as a consultant and speaker for AbbVie, Chugai, Genentech Roche, Pfizer and Sanofi. He also declares that he is an inventor on patents owned by CONARIS Research Institute, which develops the sgp130Fc protein olamkicept together with the company I-Mab. S.R.-J. has stock ownership in CONARIS. C.G. has received a research grant from Corvidia Therapeutics (Waltham, MA, USA) and has acted as a consultant for AbbVie. All other authors declare no competing interests.
